Sherlock JP - Search Results

1

IL-23 induces spondyloarthropathy by acting on ROR-γt+ CD3+CD4-CD8- entheseal resident T cells.

Sherlock JP, Joyce-Shaikh B, Turner SP, Chao CC, Sathe M, Grein J, Gorman DM, Bowman EP, McClanahan TK, Yearley JH, Eberl G, Buckley CD, Kastelein RA, Pierce RH, Laface DM, Cua DJ. Sherlock JP, et al. Nat Med. 2012 Jul 1;18(7):1069-76. doi: 10.1038/nm.2817. Nat Med. 2012. PMID: 22772566

2

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD. Cua DJ, et al. Nature. 2003 Feb 13;421(6924):744-8. doi: 10.1038/nature01355. Nature. 2003. PMID: 12610626

3

Autoimmunity's collateral damage: Gut microbiota strikes 'back'.

Cua DJ, Sherlock JP. Cua DJ, et al. Among authors: sherlock jp. Nat Med. 2011 Sep 7;17(9):1055-6. doi: 10.1038/nm0911-1055. Nat Med. 2011. PMID: 21900923 No abstract available.

4

Interleukin-23: a promising therapeutic target in seronegative spondyloarthropathy.

Sherlock JP, Cua DJ. Sherlock JP, et al. Curr Opin Pharmacol. 2013 Jun;13(3):445-8. doi: 10.1016/j.coph.2013.03.002. Epub 2013 Mar 26. Curr Opin Pharmacol. 2013. PMID: 23540587 Review.

5

What can rheumatologists learn from translational cancer therapy?

Sherlock JP, Filer AD, Isaacs JD, Buckley CD. Sherlock JP, et al. Arthritis Res Ther. 2013;15(3):114. doi: 10.1186/ar4203. Arthritis Res Ther. 2013. PMID: 23638860 Free PMC article.

6

The critical role of interleukin-23 in spondyloarthropathy.

Sherlock JP, Buckley CD, Cua DJ. Sherlock JP, et al. Mol Immunol. 2014 Jan;57(1):38-43. doi: 10.1016/j.molimm.2013.06.010. Epub 2013 Aug 1. Mol Immunol. 2014. PMID: 23910729 Review.

7

The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases.

Sherlock JP, Taylor PC, Buckley CD. Sherlock JP, et al. Curr Opin Rheumatol. 2015 Jan;27(1):71-5. doi: 10.1097/BOR.0000000000000132. Curr Opin Rheumatol. 2015. PMID: 25415528 Review.

8

Spondyloarthropathy: interleukin 23 and disease modification.

Sherlock JP, Taylor PC, Buckley CD, Cua DJ. Sherlock JP, et al. Lancet. 2015 May 23;385(9982):2017-8. doi: 10.1016/S0140-6736(15)60970-9. Lancet. 2015. PMID: 26009213 No abstract available.

9

Pathogenic stromal cells as therapeutic targets in joint inflammation.

Dakin SG, Coles M, Sherlock JP, Powrie F, Carr AJ, Buckley CD. Dakin SG, et al. Among authors: sherlock jp. Nat Rev Rheumatol. 2018 Dec;14(12):714-726. doi: 10.1038/s41584-018-0112-7. Nat Rev Rheumatol. 2018. PMID: 30420750 Review.

10

Author Correction: Pathogenic stromal cells as therapeutic targets in joint inflammation.

Dakin SG, Coles M, Sherlock JP, Powrie F, Carr AJ, Buckley CD. Dakin SG, et al. Among authors: sherlock jp. Nat Rev Rheumatol. 2019 Jan;15(1):61. doi: 10.1038/s41584-018-0134-1. Nat Rev Rheumatol. 2019. PMID: 30498256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters